Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

73.6K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
73.6K
Ethical Issues01:27

Ethical Issues

2.5K
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
2.5K
Forced Transdifferentiation01:28

Forced Transdifferentiation

2.4K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.4K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
CRISPR01:59

CRISPR

58.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Ethics of Stem Cell-Based Embryo-Like Structures : A Focus Group Study on the Perspectives of Dutch Professionals and Lay Citizens.

Journal of bioethical inquiry·2024
Same author

[Maternal-fetal therapy: from saving the fetus towards a better life for the future child].

Nederlands tijdschrift voor geneeskunde·2021
Same author

Intrafamilial oocyte donation in classic galactosemia: ethical and societal aspects.

Journal of inherited metabolic disease·2018
Same author

[Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction?]

Nederlands tijdschrift voor geneeskunde·2017
Same author

[Making embryos for research: first prohibited, now allowed?]

Nederlands tijdschrift voor geneeskunde·2016
Same author

Users evaluate a detailed familial risk questionnaire as valuable and no more time consuming than a simple enquiry in a web-based diabetes risk assessment tool.

Public health·2015

Related Experiment Video

Updated: Mar 19, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

1.1K

[Foetal therapy for Down syndrome: a pro-active ethical reflection].

G M W R de Wert1, W J Dondorp

  • 1Universiteit Maastricht, Faculty of Health, Medicine and Life Sciences, afd. Metamedica, onderzoeksscholen CAPHRI en GROW, Maastricht.

Nederlands Tijdschrift Voor Geneeskunde
|June 24, 2016
PubMed
Summary

New prenatal screening for Down syndrome may enable fetal neurocognitive therapy for Down syndrome (FTDS). Ethical considerations for clinical trials and therapy implications are discussed, with no major a priori objections found.

More Related Videos

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.6K
Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
09:51

Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators

Published on: March 21, 2018

20.6K

Related Experiment Videos

Last Updated: Mar 19, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

1.1K
Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.6K
Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
09:51

Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators

Published on: March 21, 2018

20.6K

Area of Science:

  • Medical Ethics
  • Genetics
  • Prenatal Diagnostics

Background:

  • Prenatal screening for Down syndrome traditionally focuses on pregnancy continuation decisions.
  • Non-invasive prenatal testing (NIPT) opens possibilities for novel interventions.
  • Fetal neurocognitive therapy for Down syndrome (FTDS) is a potential future application.

Purpose of the Study:

  • To proactively explore the ethical considerations of FTDS.
  • To assess the ethical permissibility of clinical trials for FTDS.
  • To examine the implications of effective FTDS for current prenatal screening practices.

Main Methods:

  • Ethical analysis based on the social model of disability.
  • Review of arguments concerning autonomy, wellbeing, and justice.
  • Discussion of prerequisites for ethical clinical trials.

Main Results:

  • No convincing a priori ethical objections to FTDS were identified based on the social model of disability.
  • Ethical principles of autonomy, wellbeing, and justice appear to support FTDS in principle.
  • Further scrutiny is needed regarding clinical trial conditions and screening implications.

Conclusions:

  • FTDS presents a potential paradigm shift in Down syndrome care, moving beyond screening to intervention.
  • Ethical frameworks generally support the exploration of FTDS, pending rigorous clinical trial evaluation.
  • The advent of effective FTDS necessitates a re-evaluation of the goals and practices of prenatal screening.